Ming Xu

机构：China Mobile (China), Shimonoseki City University, Beijing Normal University · ORCID：0000-0001-5234-2203

发表论文 69 篇 · 总被引 1088 次 · h-index 20

代表论文

Ophiopogonin D alleviates diabetic myocardial injuries by regulating mitochondrial dynamics (2021 · Journal of Ethnopharmacology · 被引 56)
Stachydrine Ameliorates Cardiac Fibrosis Through Inhibition of Angiotensin II/Transformation Growth Factor β1 Fibrogenic Axis (2019 · Frontiers in Pharmacology · 被引 47)
Shengmai San Alleviates Diabetic Cardiomyopathy Through Improvement of Mitochondrial Lipid Metabolic Disorder (2018 · Cellular Physiology and Biochemistry · 被引 40)
RETRACTED ARTICLE: SNHG6 modulates oxidized low-density lipoprotein-induced endothelial cells injury through miR-135a-5p/ROCK in atherosclerosis (2020 · Cell & Bioscience · 被引 34)
Stachydrine hydrochloride alleviates pressure overload-induced heart failure and calcium mishandling on mice (2019 · Journal of Ethnopharmacology · 被引 25)
A new mechanism of therapeutic effect of stachydrine on heart failure by inhibiting myocardial ferroptosis (2023 · European Journal of Pharmacology · 被引 22)